Ornopia, Jovito N.

HRN: 22-15-57  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/10/2022
CEFTRIAXONE 1G (VIAL)
11/10/2022
11/16/2022
IV
2gms
Od
Ugib Prob Sec To Ruptured Esophageal Varices Sec To Decompensated Liver Disease
Waiting Final Action 
12/29/2024
CEFTRIAXONE 1G (VIAL)
12/29/2024
01/04/2025
IV
2g
OD
CAP MR
Waiting Final Action 
12/30/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
12/30/2024
12/30/2024
IVTT
750 Mg
Stat Dose
Cap HR
Waiting Final Action 
12/30/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
01/01/2025
01/13/2025
IVTT
500 Mg
Every Other Day
Cap HR; Ckd
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: